Trial Profile
Randomized, Double-blind, Parallel, Controlled Clinical Study to Evaluated the Efficacy and Safety of Recombinant Human Interferon Alpha-2b Gel (Yallaferon) in HPV-16 and/or HPV-18 Infection
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon alpha-2b (Primary)
- Indications Gynaecological infections; Human papillomavirus infections
- Focus Therapeutic Use
- Sponsors Lee's Pharmaceutical
- 20 Jun 2016 New trial record